| Product Name |
Elagolix Sodium Inhouse Impurity 16 / 3-[(2R)-N-(tert-butoxycarbonyl)amino-2-phenylethyl]-2-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-2,4(1H,3H)-pyrimidinedione
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Metabolites, Pharmaceutical Standards, Fine Chemicals |
| CAS No |
830346-51-5 |
| Catalog Number |
GS.07.ELA.46N |
| Chemical Name/Synonyms |
3-[(2R)-N-(tert-butoxycarbonyl)amino-2-phenylethyl]-2-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-2,4(1H,3H)-pyrimidinedione |
| Molecular Weight |
645.63 |
| Molecular Formula |
C33H32F5N3O5 |
| Purity |
NLT 95 % |
| Applications |
N-Boc Desbutyrate Elagolix is an intermediate for the synthesis of Elagolix-d6 Sodium Salt, which is the labelled analogue of Elagolix Sodium Salt, a novel uracil phenylethylamine that acts as potent human gonadotropin-​releasing hormone receptor (hGnRH |
| Inventory Status |
customized
|
